Literature DB >> 28825332

The Incidence of Arthroplasty After Initial Arthroscopy for Trapeziometacarpal Arthrosis.

Suzanne C Wilkens1, Frederique L Vissers1, Adam Nazzal1, Neal Chen1.   

Abstract

BACKGROUND: It remains unclear how many patients undergo secondary surgery after initial arthroscopy for trapeziometacarpal (TMC) arthrosis. We studied the factors related to secondary TMC arthroplasty after TMC arthroscopy. We also examined secondary questions of: (1) what percentage of patients underwent secondary TMC arthroplasty; and (2) how much time elapsed from initial arthroscopy to arthroplasty.
METHODS: In this retrospective study, we included all adult patients who were treated with arthroscopy of the TMC joint at 2 level I hospitals and affiliates. Factors were assessed for their independent association with secondary TMC arthroplasty using bivariate and multivariable analyses.
RESULTS: Fourteen of 84 (17%) thumbs underwent secondary TMC arthroplasty an average of 11 months after the initial arthroscopy. Synovectomy alone and smoking tobacco were independently associated with secondary TMC arthroplasty when compared with arthroscopic (partial) trapeziectomy with additional tendon interposition or allograft.
CONCLUSIONS: This study demonstrated that 1 in 6 thumbs underwent secondary TMC arthroplasty, an average of 11 months after the initial arthroscopy. Coupling arthroscopy with partial trapeziectomy, interposition, or extension osteotomy may be a preferable strategy to isolated synovectomy. In addition, smoking tobacco is associated with inferior outcomes regardless of surgical procedure.

Entities:  

Keywords:  arthroplasty; arthroscopy; reoperation; risk factors; trapeziometacarpal arthrosis

Mesh:

Year:  2017        PMID: 28825332      PMCID: PMC6109896          DOI: 10.1177/1558944717725382

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  14 in total

Review 1.  Psychosocial factors related to adolescent smoking: a critical review of the literature.

Authors:  S L Tyas; L L Pederson
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

2.  Unplanned Reoperation After Trapeziometacarpal Arthroplasty: Rate, Reasons, and Risk Factors.

Authors:  Suzanne C Wilkens; Zichao Xue; Jos J Mellema; David Ring; Neal Chen
Journal:  Hand (N Y)       Date:  2016-11-15

3.  Arthroscopic debridement and synovectomy for treating basal joint arthritis.

Authors:  John P Furia
Journal:  Arthroscopy       Date:  2009-12-03       Impact factor: 4.772

4.  Long-Term Outcome of Arthroscopic Resection Arthroplasty With or Without Interposition for Thumb Basal Joint Arthritis.

Authors:  Tyson K Cobb; Anna L Walden; Ying Cao
Journal:  J Hand Surg Am       Date:  2015-06-26       Impact factor: 2.230

5.  Factors affecting the outcome of arthroscopy in medial-compartment osteoarthritis of the knee.

Authors:  Gunter Spahn; Thomas Mückley; Enrico Kahl; Gunther O Hofmann
Journal:  Arthroscopy       Date:  2006-11       Impact factor: 4.772

6.  Arthroscopic hemitrapeziectomy for first carpometacarpal arthritis: results at 7-year follow-up.

Authors:  Eric P Hofmeister; Robert S Leak; Randall W Culp; A Lee Osterman
Journal:  Hand (N Y)       Date:  2008-09-24

7.  Arthroscopic evaluation and treatment by tendon interpositional arthroplasty of first carpometacarpal joint arthritis.

Authors:  L Pegoli; C Parolo; T Ogawa; S Toh; G Pajardi
Journal:  Hand Surg       Date:  2007

8.  Arthroscopic interposition in thumb carpometacarpal osteoarthritis: A series of 26 cases.

Authors:  A Pereira; S Ichihara; S Facca; S Hendriks; S Gouzou; P Liverneaux
Journal:  Chir Main       Date:  2015-10-23

9.  Trapeziometacarpal osteoarthritis. Staging as a rationale for treatment.

Authors:  R G Eaton; S Z Glickel
Journal:  Hand Clin       Date:  1987-11       Impact factor: 1.907

10.  Arthroscopic partial trapeziectomy and tendon interposition for thumb carpometacarpal arthritis.

Authors:  Min-Yao Chuang; Chang-Hung Huang; Yung-Chang Lu; Jui-Tien Shih
Journal:  J Orthop Surg Res       Date:  2015-12-18       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.